Methylglyoxal, a Knot to Be Untied in Brain Glucose Hypometabolism.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanistic concepts without systematic search methodology or new empirical data.
PubMed 41295276 · doi:10.3390/metabo15110690
What was done
This narrative review synthesized experimental and clinical literature examining methylglyoxal (MG) generation, detoxification via the glyoxalase system, and astrocytic involvement in brain tissue. The authors analyzed interactions between MG accumulation, RAGE signaling, the unfolded protein response, the hexosamine biosynthesis pathway, and O-GlcNAcylation within the context of diabetes mellitus and Alzheimer's disease.
What was found
The abstract reports no quantitative values or effect estimates. It describes a mechanistic model where brain glucose hypometabolism driven by insulin resistance alters glycolytic flux to increase MG generation, which further compromises insulin signaling in a vicious cycle, with astrocytes acting as key regulators of MG generation and clearance.
Why it matters
The paper outlines mechanistic pathways through which reactive dicarbonyl stress may link peripheral metabolic dysfunction with neurodegenerative processes.
Limits
The abstract provides no empirical data, sample sizes, or quantitative meta-analytic results. As a narrative review, it lacks a systematic search protocol and risk-of-bias evaluation, relying primarily on mechanistic reasoning.
Cited by
- supports Methylglyoxal is a precursor to advanced glycation end products (AGEs) associated with Alzheimer's disease.